Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: A randomized controlled trial

International Journal of Neuropsychopharmacology

Volumn 14, Issue 10, 2011, Pages 1389-1397

  Mansur, Carlos Gustavo ^a   Myczkowki, Martin Luiz ^a   De Barros Cabral, Sergio ^a   Sartorelli, Maria Do Carmo Breda ^a   Bellini, Bianca Boura ^a   Dias, Álvaro MacHado ^a   Bernik, Marcio Antonini ^a   Marcolin, Marco Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Obsessive compulsive disorder; placebo effect; randomized controlled trial; transcranial magnetic stimulation; treatment resistant

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PLACEBO EFFECT; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; AMBULATORY CARE; ANALYSIS OF VARIANCE; BRAZIL; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PLACEBO EFFECT; PLACEBOS; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 80055023321     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000575     Document Type: Article

References (32)

1. Alonso P, Pujol J, Cardoner N, Benlloch L, et al. (2001). Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder : A double-blind, placebo-controlled study. American Journal of Psychiatry 158, 1143-1145. (Pubitemid 32623120)
2. Aouizerate B, Guehl D, Cuny E, Rougier A, et al. (2004). Pathophysiology of obsessive-compulsive disorder : A necessary link between phenomenology, neuropsychology, imagery and physiology. Progress in Neurobiology 72, 195-221. (Pubitemid 38591296)
3. Baxter L (1999). Functional imaging of brain systems mediating obsessive-compulsive disorder : clinical studies. In : Charney D, Nestler E, Bunney B (Eds), Neurobiology of Mental Illness (pp. 563-573). New York: Oxford University Press.
4. Ciconelli R, Ferraz M, Santos W, Meinão I, et al. (1999). Portuguese language version and validation of the SF-36 quality of life questionnaire. Revista Brasileira de Reumatologia 39, 143-150. (Pubitemid 29359720)
5. Cohen D, Consoli A, Bodeau N, Purper-Ouakil D, et al. (2010). Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders. Journal of Child and Adolescent Psychopharmacology 20, 39-47.
6. Denys D (2006). Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatric Clinics of North America 29, 553-584, xi.
7. First MB, Spitzer RL, Gibbon M, Williams JB (1970). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
8. Fitzgerald PB, Daskalakis ZJ (2011). The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Review of Medical Devices 8, 85-95.
9. Fitzgerald PB, Huntsman S, Gunewardene R, Kulkarni J, et al. (2006). A randomized trial of low-frequency rightprefrontal- cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. International Journal of Neuropsychopharmacology 9, 655-666. (Pubitemid 46122766)
10. George MS, Lisanby SH, Sackeim HA (1999). Transcranial magnetic stimulation: applications in neuropsychiatry. Archives of General Psychiatry 56, 300-311. (Pubitemid 29165173)
11. Goodman WK, Price L, Rasmussen S, Mazure C, et al. (1989a). The Yale-Brown obsessive compulsive scale (YBOCS): Part I. Development, use, and reliability. Archives of General Psychiatry 46, 1006-1011. (Pubitemid 19278229)
12. Goodman WK, Price L, Rasmussen S, Mazure C, et al. (1989b). The Yale-Brown obsessive-compulsive scale. Part II Validity. Archives of General Psychiatry 46, 1012-1016.
13. Greenberg BD, George MS, Martin JD, Benjamin J, et al. (1997). Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder : A preliminary study. American Journal of Psychiatry 154, 867-869. (Pubitemid 27230116)
14. Guy W, Bonato R (1970). CGI: Clinical Global Impressions. In : Guy W, Bonato R (Eds), Manual for the ECDEU Assessment Battery 2. Chevy Chase, MD, USA: National Institute of Mental Health.
15. Herwig U, Schonfeldt-Lecuona C, Wunderlich AP, von Tiesenhausen C, et al. (2001). The navigation of transcranial magnetic stimulation. Psychiatry Research 108, 123-131. (Pubitemid 34003574)
16. Hollander E, Bienstock CA, Koran LM, Pallanti S, et al. (2002). Refractory obsessive-compulsive disorder : state-ofthe- art treatment. Journal of Clinical Psychiatry 63 (SUPPL. 6), 20-29. (Pubitemid 34438946)
17. Kang JI, Kim CH, Namkoong K, Lee C, et al. (2009). A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessivecompulsive disorder. Journal of Clinical Psychiatry 70, 1645-1651.
18. Langner J, Laws M, Roper G, Zaudig M, et al. (2009). Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD). Behavioral and Cognitive Psychotherapy 37, 485-496.
19. Mantovani A, Simpson HB, Fallon BA, Rossi S, et al. (2010a). Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 13, 217-227.
20. Mantovani A, Westin G, Hirsch J, Lisanby SH (2010b). Functional magnetic resonance imaging guided transcranial magnetic stimulation in obsessive-compulsive disorder. Biological Psychiatry 67, 39-40.
21. Prasko J, Záleský R, Novák T, Kopecek M, et al. (2006). The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuroendocrinology Letters 27, 327-332. (Pubitemid 44390067)
22. Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P (2006). The Dimensional Yale-Brown Obsessive- Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Molecular Psychiatry 11, 495-504.
23. Rossini PM, Barker AT, Berardelli A, Caramia MD, et al. (1994). Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots : basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalography and Clinical Neurophysiology 91, 79-92. (Pubitemid 24246462)
24. Sachdev PS, Loo CK, Mitchell PB, McFarquhar TF, et al. (2007). Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder : A double-blind controlled investigation. Psychological Medicine 37, 1645-1649. (Pubitemid 47606852)
25. Sachdev PS, McBride R, Loo CK, Mitchell PB, et al. (2001). Right vs. left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder : A preliminary investigation. Journal of Clinical Psychiatry 62, 981-984. (Pubitemid 34007965)
26. Sarkhel S, Sinha VK, Praharaj SK (2010). Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression. Journal of Anxiety Disorders 24, 535-539.
27. Saxena S, Rauch SL (2000). Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatric Clinics of North America 23, 563-586. (Pubitemid 30666507)
28. Schruers K, Koning K, Luermans J, Haack MJ, et al. (2005). Obsessive-compulsive disorder : A critical review of therapeutic perspectives. Acta Psychiatrica Scandinavica 111, 261-271. (Pubitemid 40445031)
29. Shavitt RG, Belotto C, Curi M, Hounie AG, et al. (2006). Clinical features associated with treatment response in obsessive-compulsive disorder. Comprehensive Psychiatry 47, 276-281. (Pubitemid 43870063)
30. Shetti CN, Reddy YC, Kandavel T, Kashyap K, et al. (2005). Clinical predictors of drug nonresponse in obsessive-compulsive disorder. Journal of Clinical Psychiatry 66, 1517-1523. (Pubitemid 43068689)
31. Ulloa RE, Nicolini H, Avila M, Fernandez-Guasti A (2007). Age onset subtypes of obsessive compulsive disorder : differences in clinical response to treatment with clomipramine. Journal of Child and Adolescent Psychopharmacology 17, 85-96. (Pubitemid 46452084)
32. Weissman MM, Bland R, Canino G, Greenwald S, et al. (1994). The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. Journal of Clinical Psychiatry 55 (SUPPL.), 5-10. (Pubitemid 24113069)